Massive french study probes AntiTNFα risks in pregnant IBD patients
NCT ID NCT03134508
First seen Mar 14, 2026 · Last updated May 01, 2026 · Updated 3 times
Summary
This study looked at over 8,700 pregnant women with inflammatory bowel diseases (Crohn's or colitis) to see if using antiTNFα drugs during pregnancy is safe and follows guidelines. Researchers checked for complications in both mothers and babies up to one year after birth. The goal was to better understand the risks and benefits of these treatments during pregnancy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chu de Dijon
Dijon, France
Conditions
Explore the condition pages connected to this study.